Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.

September 14, 2016

Bayer and Monsanto to Create a Global Leader in Agriculture

Realizes a shared vision of integrated agricultural offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of farming. USD 128 per share in all-cash transaction, represents 44 percent premium to Monsanto shareholders and an aggregate value of USD 66 billion. Significant value creation with expected annual synergies of approximately USD 1.5 billion after year three; plus additional synergies from integrated solutions in future years. Bayer shareholders expected to benefit from accretion to core EPS in the first full year after closing and double-digit percentage accretion in the third full year. Committed to retaining strong presence in the U.S. with the combined business’ global Seeds & Traits and North American commercial headquarters in St. Louis. Read more
September 01, 2016

Bayer Inc. Launches the First DNA Immunostimulant in Canada for Bovine Respiratory Disease (BRD)

Zelnate® jumpstarts animal's innate immunity, offering an innovative non-antibiotic approach to help mitigate BRD Read more
August 26, 2016


Introducing Help Strike-Out Arthritis from ALEVE®. For every home game strike-out by a Blue JaysTM reliever, ALEVE will donate $1,200 to The Arthritis Society of Canada Read more
August 17, 2016

Bayer and the Canadian Vascular Network (CVN) Announce the 2016 Research Fellowship Awards

Two Recipients Selected, Dr. Jason Christopher Weatherald and Dr. Don Thiwanka Dilshan Wijeratne Read more
June 10, 2016

Wheat Breeding Station leverages Bayer's global program to find local solutions for Canadian wheat growers

New varieties and traits will be tailored to the unique challenges Canadian growers face, enhancing their ability to remain competitive in global markets Read more
May 24, 2016

Bayer Comments on Monsanto's Statement Regarding P...

Bayer announced today that it looks forward to eng... Read more
April 18, 2016

New Data Reaffirm Positive Benefit-Risk Balance of Bayer’s Xarelto®

Bayer AG and its development partner Janssen Pharmaceuticals, Inc. today announced results from a new real-world study, REVISIT-US. Read more
March 07, 2016

Canadian Olympic skiers, the Dufour-Lapointe sisters, ask millennial women, what are your #3YearGoals and how will you achieve them?

A recent survey revealed that 75 per cent of millennial women say that an unintended pregnancy would make it very difficult to achieve their goals. Read more
February 25, 2016

Another record year for Bayer

Focus on the Life Sciences following the successful stock market flotation of Covestro / Substantial sales and earnings increases at HealthCare / Good business development at CropScience despite a weaker market environment / Covestro posts strong earnings improvement Read more
February 24, 2016

Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG

Effective May 1, 2016, Werner Baumann will become the new Chairman of the Board of Management of Bayer AG. Read more